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Background/Purpose: The purpose of this study is to examine the association between age and metabolic
disorders in the population of Bali.
Method: A cross-sectional study was conducted on metabolic syndrome (MS) as deﬁned on the basis of
recommended parameters for diagnosis of the syndrome in the population of seven villages of Bali
comprising six villages and one suburban area. At least three of the ﬁve parameters must be present for
the diagnosis. Three hundred ten elderly people aged 60 years or more, with a male:female ratio of
168:142, of 1840 subjects were recruited in the study. The criteria for obesity were based on the 2000
World Health Organization recommendations for Asia Paciﬁc population, for prediabetes [impaired
fasting glycemia (IFG) and impaired glucose tolerance] and diabetes mellitus (DM) by American Diabetes
Association (2009), and for MS by a joint statement of International Diabetes Federation, National Heart,
Lung, and Blood Institute, American Heart Association, World Heart Federation, International Athero-
sclerosis Society, and International Association for the Study of Obesity (2009).
Results: The prevalence of IFG and DM were twofold in the elderly as compared with those in the
younger-aged groups (21.4 vs. 11.7; 11.7 vs. 4.8, respectively). Blood pressure and fasting blood sugar
levels were higher in the elderly than in the younger-aged group (133/81 mmHg vs. 117/76 mmHg;
102.7 mg/dL vs. 93.0 mg/dL, respectively; p < 0.001). There was no statistically signiﬁcant difference in
triglyceride and high-density lipoprotein cholesterol levels between both groups. Waist circumferences
were lower among the elderly than among younger-aged groups (75.8 cm vs. 80.9 cm; p < 0.001). The
elderly, with lower waist circumference, revealed signiﬁcantly higher prevalence of MS as compared
with the younger-aged group {22.9% vs. 17.3%; p ¼ 0.026; prevalence risk 1.423 [conﬁdence interval
(CI) ¼ 1.043–1.944]}. The subjects who had 1, 2, 3, 4, and 5 components of MS were 34.6%, 23.8%, 13.0%,
4.3%, and 0.9%, respectively. The prevalence risk of each component of MS for the occurrence of MS
were: elevated triglyceride [30.2 (CI ¼ 14.5–63.1)], elevated fasting blood sugar [8.5 (CI ¼ 4.5–15.8)],
increased waist circumference [8.1 (CI ¼ 4.3–15.0)], reduced high-density lipoprotein cholesterol [4.4
(CI ¼ 2.4–7.9)], and elevated blood pressure [3.7 (CI ¼ 1.9–7.2)].
Conclusions: It could be inferred that in comparison with the younger-age group, the elderly had higher
(twice) prevalence of IFG and DM, lower prevalence of central obesity, but higher prevalence of MS. Old
age (60 years and more) had 1.4-fold risk for MS as compared with that in the younger-aged group, and
elevated triglyceride levels appeared to be the most important risk factor for MS.
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The number of elderly population has increasedworldwide; and
recently, it has been increasing sharply in the developing countries.
The projection of elderly population in Indonesia by the year 2010
is 23,992. The Indonesian Central Bureau for Statistics (Badan Pusatublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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number of elderly population after China, India, and the United
States.1 The island of Bali is one among 11 provinces in Indonesia
that has a relatively high proportion of elderly population, that is,
11.02%.2 United States Bureau of Census predicted that from 1990 to
2020, the Indonesian elderly population would increase to 41.4%.3
The predicted increased number of elderly was ascribed to the
success of health promotion and improvement of social and
economic status.3 A ﬁeld study in 1990 by World Health Organi-
zation (WHO), World Bank, and Harvard University found
a changing pattern of diseases caused by unhealthy lifestyle
changes that may eventually lead to metabolic syndrome (MS),
Type 2 diabetes mellitus (DM), coronary arterial diseases, depres-
sion, and trafﬁc accidents. The study also predicted that cerebro-
vascular diseases would become the most prevalent disease,
whereas human HIV infection would sharply increase in the year
2020.4
Metabolic disorders are closely related with aging process.
Central obesity and its consequences are frequently found among
the elderly. The development of insulin resistance is likely to
become one of the most important risk factors for metabolic
diseases in the elderly. Decline in lean body mass and increase in
body fat, particularly visceral adiposity that often accompanies
aging may contribute to the development of insulin resistance. As
for the mechanism of Type 2 DM, it is known that aging induces
decrease of insulin sensitivity and alteration or insufﬁcient
compensation of beta-cell functional mass in the face of increasing
insulin resistance.5 Related to beta-cell functions, aging correlates
with decrease of beta-cell proliferation capacity and enhances
sensitivity to apoptosis.6 It has recently been proposed that an age-
associated decline in mitochondrial function contributes to insulin
resistance in the elderly. Mitochondrial oxidative and phosphory-
lation function was reduced by about 40% in association with
increased intramyocellular and intrahepatocellular lipid content
and decreased insulin-stimulated glucose uptake.7 Other metabolicFig. 1. Map of Bali Island: locations of thediseases are also frequently related with aging, such as coronary
arterial disease, malignancies, cognitive disorders, and vitamin D
deﬁciency.8,9
The purpose of this study was to study metabolic disorders
(obesity, MS, and glucose intolerance) in the elderly in comparison
with younger-aged group.
2. Methods
A survey (cross-sectional study) was conducted on obesity, MS
and its components, and glucose intolerance (prediabetes and DM)
in the populations of seven villages of Bali, Indonesia, comprising
six villages and one suburban area. The villages were the village of
Sangsit (seashore area, 471 subjects), Pedawa (mountainous area,
aboriginal Balinese, 294 subjects), Ubud (lowland and tourism area,
301 subjects), Tenganan (highland area, aboriginal Balinese, 81
subjects), Ceningan (remote island, 305 subjects), Legian (beach
and tourism area, 288 subjects), and Pengelipuran (highland, 100
subjects) (Fig. 1). Three hundred ten elderly [aged 60 years or more;
male-to-female ratio (168/142)] of a total of 1840 subjects were
recruited in the study.
The variables measured included age, waist circumference, body
mass index (BMI), blood pressure, plasma lipids, fasting, and
2-hour postprandial blood glucose. The criteria for obesity was
based on the 2000 WHO recommendation for Asia Paciﬁc Pop-
ulation.10 Classiﬁcation of prediabetes [impaired fasting glycemia
(IFG) and impaired glucose tolerance (IGT)] and DM was based on
the guidelines set out by American Diabetes Association in 2009,11
that is, IFG if fasting blood glucose level was 100 mg/dL or higher
and below 126 mg/dL; IGT if fasting blood glucose levels was below
100 mg/dL and 2-hour postprandial blood glucose levels was
between 140 mg/dL or higher and below 200 mg/dL; and diabetes
if fasting blood glucose levels was 126 mg/dL or higher. The diag-
nosis of MS was established on the basis of criteria and parameters
as set out in the joint statement of International Diabetesseven villages involved in the study.
Table 1
Characteristic of metabolic states in younger and elderly subjects
Variables <60 yr
(n¼ 1530)
60 yr
(n¼ 310)
p
Body mass index (kg/m2) 23.1 4.1 21.0 4.6 <0.001
Waist circumference (cm) 80.9 11.9 75.8 12.5 <0.001
Systolic blood pressure (mmHg) 117.5 16.7 132.6 23.1 <0.001
Diastolic blood pressure (mmHg) 75.8 10.3 81.1 11.7 <0.001
Fasting blood glucose (mg/dL) 93.0 27.9 102.7 40.0 <0.001
Postprandial blood glucose (mg/dL) 106.7 48.9 133.9 94.0 NS
Total-cholesterol (mg/dL) 186.0 37.6 198.8 42.4 <0.001
LDL-cholesterol (mg/dL) 120.1 30.6 131.8 35.0 <0.001
HDL-cholesterol (mg/dL) 50.4 13.3 49.9 15.4 NS
Triglyceride (mg/dL) 120.0 75.1 124.2 66.8 NS
HDL¼ high-density lipoprotein; LDL¼ low-density lipoprotein; NS¼ not signiﬁcant.
Table 3
Prevalence risk (odds ratio) of the elderly subjects for metabolic syndrome
Age Metabolic
syndrome
negative (%)
Metabolic
syndrome
positive (%)
Prevalence
risk (odds
ratio)
95%
Conﬁdence
interval
p
<60 yr (n¼ 1405) 82.7 17.3 1.423 1.043e1.944 0.026
 60 yr (n¼ 279) 77.1 22.9
K. Suastika et al. / Journal of Clinical Gerontology & Geriatrics 2 (2011) 47e52 49Federation (IDF), National Heart, Lung, and Blood Institute, Amer-
ican Heart Association, World Heart Federation, International
Atherosclerosis Society, and International Association for the Study
of Obesity in 2009.12 MS was diagnosed if three of ﬁve parameters
were present: increased waist circumference (male>90 cm, female
>80 m), elevated triglycerides (drug treatment for elevated
triglycerides is an alternate indicator; 150 mg/dL), reduced high-
density lipoprotein (HDL) cholesterol (drug treatment for reduced
HDL-cholesterol is an alternate indicator; 40 mg/dL in males and
50 mg/dL in females), elevated blood pressure (antihypertensive
drug treatment in a patient with a history of hypertension is an
alternate indicator; systolic 130 mmHg and/or diastolic
85 mmHg); elevated fasting glucose (drug treatment of elevated
glucose is an alternate indicator; 100 mg/dL).12
Blood glucose levels was measured by the hexokinase method
(Hitachi 912; Roche Diagnostic GmbH, Mannheim, Germany); total
cholesterol level was measured by CHOD PAP (CHOD, cholesterol
oxidase; PAP, phenol þ aminophenazone) (Hitachi 912; Roche
Diagnostic GmbH); low-density lipoprotein cholesterol level was
measured by enzymatic/homogenous method (Hitachi 912; Roche
Diagnostic GmbH); HDL-cholesterol level was measured by enzy-
matic/homogenous method (Hitachi 912; Roche Diagnostic
GmbH); and triglyceride level was measured by GPO PAP (GPO,
glycerol-3-phosphate oxidase; PAP, phenol þ aminophenazone)
method (Hitachi 912; Roche Diagnostic GmbH).
Statistical tests used to analyze the data in the study include
descriptive presentation, independent t test, cross-tab (c2 test and
prevalence risk or odds ratio), with signiﬁcant value conﬁrmed at
p less than 0.05.
3. Results
A total of 310 elderly subjects of 1840 subjects were enrolled in
this study. Because of some technical difﬁculty in collecting data in
the villages, we could only examine 268 subjects for their 2-hours
postprandial blood glucose level (only subjects from Legian Village,
a suburban area). Table 1 shows that although the elderly group had
lower BMI and waist circumference, they had signiﬁcantly higher
blood pressure and higher level of cholesterol than the younger-
aged group.Table 2
Frequency of metabolic syndrome and its components by age (years)
Metabolic syndrome and its components w19 (%) 20e29 (%) 3
Metabolic syndrome 5.5 4.8 1
Increased waist circumference 12.5 24.6 3
Elevated triglyceride 1.7 10.3 2
Reduced HDL-cholesterol 25.9 31.3 3
Elevated blood pressure 12.5 15.1 1
Elevated fasting blood glucose 6.9 9.5 1
HDL¼ high-density lipoprotein.A tendency was noted for the increasing frequency of MS and its
components with the increasing age (Table 2). Blood pressure and
fasting blood sugar level were higher in the elderly than in the
younger-aged group (133/81 mmHg vs. 117/76 mmHg; 102.7 mg/dL
vs. 93.0 mg/dL, respectively; p< 0.001), whereas no difference was
seen in triglyceride and HDL-cholesterol levels between the two
groups. Waist circumference was lower among the elderly than the
younger-aged groups (75.8 cm vs. 80.9 cm; p< 0.001); however,
the elderly had a signiﬁcantly higher prevalence of MS than the
younger-aged group {22.9% vs. 17.3%; p¼ 0.026; prevalence risk
1.423 [conﬁdence interval (CI¼ 1.043e1.944)]} (Table 3). The
proportion of the study subjects who had 1, 2, 3, 4, and 5 compo-
nents of MS were 34.6%, 23.8%, 13.0%, 4.3%, and 0.9%, respectively.
The frequency of MS in the female subjects was higher signiﬁcantly
than in the male subjects (29.4% vs. 17.6%, p¼ 0.021) (Fig. 2). Of the
ﬁve criteria for MS, it was obvious that elevated triglyceride was the
most important risk factor in contributing the event of MS (30.2
time vs. normal triglyceride), followed by in the order of decreasing
frequencies: elevated fasting blood glucose (8.5 time vs. normal
fasting blood glucose), increased waist circumference (8.1 time vs.
normal waist circumference), reduced HDL-cholesterol (4.4 time
vs. normal HDL-cholesterol), and elevated blood pressure (3.7 time
vs. normal blood pressure) (Table 4).
There was a tendency of increasing frequency of IFG and DM
with increasing age. Because only a few data of 2-hours post-
prandial blood glucose levels were available from the study, the
results of IGT might have not reﬂected the real condition (Table 5).
The prevalence of IFG and DM were twofold in the elderly as
compared with the younger groups (21.4 vs. 11.7; 11.7 vs. 4.8;
respectively). Among the elderly, no signiﬁcant difference was seen
in the frequency of normoglycemia (67.3% vs. 66.4%), IFG (20.4% vs.
22.6%), and DM (12.3% vs. 10.9%), between male and female elderly.
The summary of the frequency of MS, IFG, and DM in the elderly
and in the younger-aged group is presented in Fig. 3.
4. Discussion
The study has clearly showed the elderly had lower BMI and
waist circumference as compared with the younger-aged group,
but the elderly had higher blood pressure and level of fasting blood
glucose, and a tendency was noted for higher levels of triglyceride
and lower levels of HDL-cholesterol. Lower BMI and waist
circumference in the elderly might be because of lower food intake
among them. However, lower waist circumference was not signif-
icantly related to insulin resistance causing MS and glucose intol-
erance in the elderly. The fact showed that the frequency of MS, IFG,0e39 (%) 40e49 (%) 50e59 (%) 60e69 (%) 70 (%)
5.9 17.6 29.6 26.0 17.3
7.9 40.1 43.6 29.7 13.8
4.6 26.1 31.3 25.9 18.3
4.2 27.6 30.2 33.5 31.4
9.2 31.5 45.8 55.1 60.0
2.9 17.3 27.4 34.9 29.9
Fig. 2. (A) Frequency of number of components of metabolic syndrome; (B) Frequency of metabolic syndrome by sex (p¼ 0.021) in the elderly. MS¼metabolic syndrome.
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younger-aged group. Central obesity was unlikely to be the most
important risk for MS and glucose intolerance in the elderly.
The Third National Health and Morbidity Survey conducted in
Malaysia on 4746 individuals aged 60 years and older revealed the
prevalence of overweight and obesity in men as 29.2% and 7.4%
respectively; and in women as 30.3% and 13.8%, respectively. The
prevalence of abdominal obesity was 21.4%, with 7.7% in men and
33.4% in women. Predictors of adiposity include the following:
Malay and Indian ethnicity, higher education level, higher house-
hold income, from urban area, and being married.13 Data from the
Elderly Nutrition and Health Survey in Taiwan during 1999e2000
showed that the prevalence of obesity was 29.0% in men and 36.8%
in women by obesity for Asians (BMI 25 kg/m2). Waist circum-
ference as risk factor for cardiovascular diseases was more sensitive
than BMI and waist-to-hip ratio.14 The prevalence of central obesity
in the elderly people in Beijing was signiﬁcantly higher, that is,
67.3%.15 Survey on obesity in the urban elderly population ( 60
years) in Barbados revealed that women had higher rates of obesity
by BMI more than 30 kg/m2 (31% vs. 11.9%), high-risk waist
circumference (61.9% vs. 13.9%), and disease comorbidity risk (51.1%
vs.17.5%) compared withmen.16 A cross-sectional study was carried
out in 2001 on elderly people ( 60 years) in Spain by Gutierrez-
Fisac et al.17 The mean BMI was 28.2 kg/m2 in men and 29.3 kg/m2
in women. The prevalence of overweight and obesity in men wasTable 4
Prevalence risk (odds ratio) of component of metabolic syndrome on the metabolic
syndrome event in the elderly
Component of metabolic syndrome Metabolic syndrome event
Prevalence risk
(odds ratio)
95% Conﬁdence
interval
p
Elevated triglyceride 30.2 14.5e63.1 <0.001
Elevated fasting blood glucose 8.5 4.5e15.8 <0.001
Elevated waist circumference 8.1 4.3e15.0 <0.001
Reduced HDL-cholesterol 4.4 2.4e7.9 <0.001
Elevated blood pressure 3.7 1.9e7.2 <0.001
HDL¼ high-density lipoprotein.
Table 5
Frequency of impaired fasting glycemia diabetes mellitus by age (years)
Classiﬁcation w19 (n¼ 59) 20e29 (n¼ 201) 30e39 (n¼ 454)
Normoglycemia 93.1 90.5 87.1
Impaired fasting glycemia 6.9 7.0 10.9
Diabetes mellitus 0 2.5 2.049% and 31.5%, respectively. The corresponding percentages in
women were 39.8% and 40.8%. The prevalence of central obesity
was 48.4% in men and 78.4% in women.
There are different ﬁgures in the percentage of obesity both by
BMI and waist circumference by countries; the difference may be
because of different criteria for obesity between Asian people and
Caucasian people. However, the average prevalence of obesity in
the elderly people in European or American countries is higher
than that in Asian Countries. Although obesity, especially central
obesity, is relatively lower in Asian people as compared with
Caucasian people, it has been consistently proved as a risk factor for
cardiovascular diseases even in lower value.
MS in the elderly should be given proper attention because it is
related with cardiovascular events beside physical dependence,
cognitive dysfunction, depressive symptoms, anxiety symptoms,
high psychosocial risk index, and poorer health-related quality of
life.18 Aging is an important factor that affects the metabolic
abnormality, and aging of the population would lead to increase in
the prevalence of MS.19 As this study has shown, the frequency of
MS and its components increased with the increase of age. Elevated
blood pressure was the most frequent contributor for MS in the
elderly (Table 2). Age more than 60 years was 1.4 times higher risk
for MS than that below 60 years. Although blood pressure was the
most frequent variable found as the component of MS, actually
elevated triglyceride level was the most important predictor for MS
event, with 30 times greater risk prevalence. This means that an
elderly individual who has triglyceride level above 150 mg/dL has
risk for MS 30 times greater than those who have lower level of
triglyceride.
The prevalence of MS in elderly people in Beijing by the National
Cholesterol Education Program was 30.5% (17.6% in men, 39.2% in
women); but based on the new IDF deﬁnition, the prevalence
signiﬁcantly increased to 46.3% (34.8% in men, 54.1% in women).
Individuals with MS are deﬁned by signiﬁcant elevated odds ratios
for coronory heart disease, stroke, and peripheral arterial disease.15
By using Modiﬁed ATP III, a study on MS in Japan showed that the
prevalence of MS in men was 19.0% in middle-aged people (40e64
years) and 21.4% in the elderly (not signiﬁcantly different), and in
women 9.0% in middle-aged people (40e64 years) and 26.8% in the40e49 (n¼ 490) 50e59 (n¼ 304) 60e69 (n¼ 199) 70 (n¼ 111)
82.7 72.6 65.1 70.1
11.7 16.9 23.4 17.8
5.6 10.5 11.5 12.1
Fig. 3. (A) Frequency of normoglycemia (NG), impaired fasting glycemia (IFG), diabetes mellitus (DM) by sex in elderly; (B) Frequency of metabolic syndrome (MS), impaired fasting
glycemia, and diabetes mellitus in the younger-aged and elderly. DM¼ diabetes mellitus; IFG¼ impaired fasting glycemia; MS¼metabolic syndrome; NG¼ normoglycemia.
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et al20 revealed that the prevalence of MS was 27.2% and higher
in women (33.3%) than in men (19.6%). Based on Kooperative
gesundheitsforschung in der Region Augsburg (KORA) Survey 2000,
the prevalence of MS by the National Cholesterol Education
Program, WHO, and IDF were 24%, 38%, and 46% among women,
respectively and 28%, 50%, 57% among men, respectively.21
In general, the prevalence of MS in Asian and Caucasian elderly
people is very similar. Most studies have revealed that the preva-
lence of MS, including that in this study, was higher inwomen than
in men. But, KORA Survey has found the opposite that the preva-
lence of MS was higher in men. The frequencies of components of
MS found in this study were lower if compared with the ﬁndings of
the study done by He et al15 in Beijing.
Similar to MS, the prevalence of IFG and DM increased with
rising age. Unfortunately, there was limitation of the study inwhich
there was only limited subjects who were examined for their 2-
hours postprandial glucose levels. Trend of prevalence of IGT by age
was not seen in the study. It caused by the technical difﬁculty faced
in assessing blood glucose levels after glucose loading in the
villages. The prevalence of IFG and DM were higher in the elderly
than in the younger-aged group (nearly twofold and more than
twofold, respectively). By sex, no difference was found in the
prevalence of normoglycemia, IFG, and DM in the elderly (between
male and female).
Data from rural Taiwan showed that the prevalence of DM was
16.9% and IFG was 25.5% among elderly Chinese in 2000. During
a 5-year follow up, cumulative prevalence of DM and IFG were
23.7% and 27.9%, respectively. The 5-year cumulative incidence of
newly onset diabetes was 6.8%. Hypertension, overt proteinuria, IFG,
and high total cholesterol were independent risk factors for new
onset diabetes.22 The MEDIS (MEDiterranean ISlands) Study on the
prevalence of DM among elderly living inMediterranean Islands has
found that 21% males and 23% females had DM. Diabetic individuals
had higher prevalence of hypertension (80% vs. 64%) and hyper-
cholesterolemia (63% vs. 51%) and reported to have lower physical
activity compared with nondiabetic participants.23 In United States,
the annual incidence of diabetes increased by 23% between
1994e1995 and 2003e2004, and the prevalence increased by 62%. It
therefore has increased the burden of ﬁnancing for provision of
health care for people older than 65 years.24
The prevalence of DM among elderly Balinese was lower than
among those in other countries. Lower prevalence of obesity, lower
food intake, more physical activity especially in the rural areas,
might have some inﬂuence on the results. The difference criteria for
obesity (by BMI and waist circumference) and for the elderly
between Asian population and Caucasian population might also be
because of the difference in ethnicity between our study and otherstudies, especially those conducted inWestern countriesmight also
cause the difference in results.
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